Articles From: - Researchers to Present Data on Improving the Understanding of PNH and aHUS and Underscoring the Effectiveness of Soliris® (eculizumab) Treatment at ASH 2014 Annual Meeting to - Hyperion Therapeutics Announces Third Quarter 2014 Financial Results


Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that researchers will present data from clinical studies of Soliris ® (eculizumab) in patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), two life-threatening and ultra-rare diseases caused by chronic uncontrolled complement activation, as well as data from the Global aHUS Registry, at the 56 th Annual Meeting of the American Society of Hematology (ASH). Soliris is the first and only approved treatment for PNH and aHUS.
Sign-up for - Researchers to Present Data on Improving the Understanding of PNH and aHUS and Underscoring the Effectiveness of Soliris® (eculizumab) Treatment at ASH 2014 Annual Meeting investment picks
http://media.marketwire.com/attachments/201311/68267_unipixel.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1156650&ProfileId=051205&sourceType=1 THE WOODLANDS, TX --
Sign-up for - UniPixel Reports Third Quarter 2014 Results investment picks
2014/11/6
SEATTLE , Nov.
Sign-up for 2014/11/6 - CTI BioPharma Announces Proposed Public Offering of Convertible Preferred Stock investment picks
Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported its results for the fourth quarter and fiscal year ended September 27, 2014.
Sign-up for - Span-America Reports Fourth Quarter and Fiscal Year 2014 Results investment picks
http://media.marketwire.com/attachments/201402/71846_hansenlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1157121&ProfileId=051205&sourceType=1 MOUNTAIN VIEW, CA --
Sign-up for - Hansen Medical Reports Third Quarter 2014 Operating Results and Recent Business Highlights investment picks
- - Strong Sales and Earnings Growth - - COLUMBUS, Ohio , Nov.
Sign-up for - Mettler-Toledo International Inc. Reports Third Quarter 2014 Results investment picks
Global Net Product Sales for PROCYSBI ® of $23.8 Million for Third Quarter 2014 PROCYSBI Revenue of $52.2 Million Reached Through September 2014 PROCYSBI Revenue Guidance of $65-$70 Million Maintained 2014 Cash Operating Expense Guidance Narrowed to $80-$85 Million NOVATO, Calif., Nov.
Sign-up for - Raptor Pharmaceutical Reports Third Quarter 2014 Financial Results and Provides Corporate Update investment picks
FXCM Inc. (NYSE:FXCM), a leading online provider of foreign exchange, or FX, trading and related services, today announced for the quarter ended September 30, 2014, U.S. GAAP revenues of $116.1 million, compared to $113.2 million for the quarter ended September 30, 2013, an increase of 3%. U.S. GAAP net income attributable to FXCM Inc. was $2.4 million for the Third Quarter 2014 or $0.05 per diluted share, compared to U.S. GAAP net loss of $5.1 million or $0.15 per diluted share for the Third Quarter 2013.
Sign-up for - FXCM Inc. Announces Third Quarter 2014 Results investment picks
By Wallace Witkowski and Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch) -- Walt Disney Co.
Sign-up for - UPDATE: Disney's stock slides as quarterly earnings lack magic investment picks
Salix Pharmaceuticals Ltd.
Sign-up for - Salix Pharma shares fall on disappointing outlook, CFO resignation investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G025722-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/6/11G025722/Parkland_Fuel_Corporation(vertical)-795820231794.jpg RED DEER, AB--(Marketwired - November 06, 2014) - Parkland Fuel Corporation ("Parkland" or the "Corporation") (TSX: PKI), North America's fastest growing distributor and marketer of fuels and lubricants, today announced the financial and operating results for the three and nine months ended September 30, 2014.
Sign-up for - Parkland Fuel Corporation Reports Adjusted EBITDA of $35 Million for the Third Quarter of 2014 and Reconfirms Guidance for 2014 and 2015 investment picks
http://media.marketwire.com/attachments/201411/81495_kosslogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1157082&ProfileId=051205&sourceType=1 MILWAUKEE, WI --
Sign-up for - NASDAQ Approves Koss' Application to Transfer to the Capital Market investment picks
2014/11/6
Convenience in the kitchen is important.
Sign-up for 2014/11/6 - Pfister® REACT™ Touch-Free Kitchen Faucets Offer Purposeful Technology and Convenience in the Kitchen investment picks
2014/11/6
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1157074&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for 2014/11/6 - FBC Looks to Sell COCO-AMO Products Through the Largest Health & Beauty Distributor in the US investment picks
Gateway One Lending & Finance (“Gateway One”), a subsidiary of TCF National Bank and an indirect subsidiary of TCF Financial Corporation (“TCF”) (NYSE: TCB), today announced it was named as the leading non-prime lender by Auto Finance News and Royal Media in the Auto Finance Performance survey that received 9,793 responses from nationwide dealers.
Sign-up for - Gateway One Lending & Finance Earns a Top Spot in Auto Finance Performance Survey investment picks
2014/11/6
LITTLETON, Colo.
Sign-up for 2014/11/6 - Ur-Energy Announces R.A.F. Penrose Gold Medal Awarded to James Franklin investment picks
2014/11/6
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Texas on behalf of purchasers of Willbros Group, Inc. (“Willbros” or the “Company”) (NYSE: WG) common stock during the period between August 4, 2014 and October 21, 2014, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until December 29, 2014 to seek appointment as lead plaintiff.
Sign-up for 2014/11/6 - SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Willbros Group, Inc. To Contact Brower Piven Before The December 29, 2014 Lead Plaintiff Deadline In Class Action Lawsuit investment picks
2014/11/6
In recognition of Native American Heritage Month this November, Comcast will offer a collection of Native American content across Xfinity On Demand platforms including month-long unlimited access to a selection of films curated by Ian Skorodin .
Sign-up for 2014/11/6 - Comcast Celebrates Native American Heritage Month with Enhanced Programming investment picks
2014/11/6
Visa Inc. (NYSE:V), the global leader in payments, today announced the company’s commitment to a “Healthy & Vibrant” San Francisco, including collaboration with five strategic community partner organizations.
Sign-up for 2014/11/6 - Visa Announces Strategic Community Partners for a “Healthy & Vibrant” San Francisco investment picks
http://media.marketwire.com/attachments/200710/373693_AAONLogoPMS300.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1157018&ProfileId=051205&sourceType=1 TULSA, OK --
Sign-up for - AAON Reports Regular Semi-Annual Cash Dividend investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1157101&ProfileId=051205&sourceType=1 SAN MATEO, CA --
Sign-up for - UPDATE: Opera Mediaworks Partners With Viggle to Introduce Add-to-DVR Technology investment picks
-- UCD Product Portfolio Generates $26.2 Million in Net Sales During the Quarter --
Sign-up for - Hyperion Therapeutics Announces Third Quarter 2014 Financial Results investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: - Researchers to Present Data on Improving the Understanding of PNH and aHUS and Underscoring the Effectiveness of Soliris® (eculizumab) Treatment at ASH 2014 Annual Meeting to - Hyperion Therapeutics Announces Third Quarter 2014 Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent